3 months ago
2
Collaboration betwixt Australia and India successful beingness sciences and biotechnology is opening to output aboriginal results pursuing the Australia-India Economic Cooperation and Trade Agreement, with Queensland positioning itself arsenic a cardinal spouse for Indian companies and institutions crossed objective research, translational subject and healthcare innovation.
This momentum was highlighted during an exclusive media roundtable held connected the sidelines of BioAsia 2026 successful Hyderabad connected Tuesday, wherever members of a Queensland delegation spoke astir expanding practice successful biosciences, objective trials, academia and precocious healthcare technologies.
Speaking connected the objective probe landscape, Ravindra Gandham, main advisor with Nucleus Network, said Australia offered beardown capabilities successful early-phase objective trials, portion India brought ambition and a increasing biotechnology sector. He outlined Nucleus Network’s absorption connected Phase 1 objective trials, with operations based successful Brisbane and planetary offices successful the US and the UK pursuing its acquisition of Hammersmith Medicines Research.
Highlighting regulatory and workforce advantages, Thu (Sue) Nguyen, laminitis and CEO of Clueo Clinicals, said Queensland provided 1 of the fastest support pathways globally for early-phase objective trials. She said approvals nether Australia’s Clinical Trial Notification Scheme, overseen by the Therapeutic Goods Administration, could beryllium secured wrong 4 to 8 weeks, importantly faster than successful galore different jurisdictions.
Research into tropical wellness and infectious diseases was different country identified arsenic a earthy constituent of convergence. Andreas Kupz of the James Cook University Australian Institute of Tropical Health and Medicine outlined enactment connected vaccines and therapeutics for diseases specified arsenic tuberculosis, dengue and malaria, alongside earthy merchandise find based connected Australia’s biodiversity and probe into vector-borne illness control. Mr.Kupz said similarities successful clime and illness load created beardown scope for collaboration betwixt India and Australia, peculiarly successful manufacturing and deployment.
Prasad KDV Yarlagadda OAM, dean astatine the University of Southern Queensland, cautioned against uncritical adoption of AI successful healthcare and research. He said AI should beryllium utilized to assistance and accelerate processes alternatively than regenerate quality expertise, peculiarly successful areas specified arsenic cause and vaccine development.
Emphasising the value of large-scale collaboration, Tamanna Monem of the QIMR Berghofer Medical Research Institute said the collaboration was indispensable to advancing therapies and technologies and noted that the institute maintained hundreds of partnerships globally. “India’s standard and speed, combined with Queensland’s integrated ecosystem of government, academia and industry, offers important opportunities to deepen cooperation,” she added.
